Worth reading
54Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Announced details
MANI Micro Forceps "360 Grip"
Applicable field (uses covered by this announcement)
Ophthalmic vitreous surgery, including surgery for retinal and vitreous diseases such as retinal detachment, epiretinal membrane and macular hole
Launch dateDomestic launch scheduled for 24 November 2026
Registration number and expiry date
Medical device certification number: 304ABBZX00017000
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | MANI Micro Forceps "360 Grip" |
| Launch date | Domestic launch scheduled for 24 November 2026 |
| Applicable area | Ophthalmic vitreous surgery, including surgery for retinal and vitreous diseases such as retinal detachment, epiretinal membrane and macular hole |
| Registration number and expiry date | Medical device certification number: 304ABBZX00017000 |
Items this document does not state (14)
CounterpartyCounterparty overviewRelationship with the CompanyContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyLocationLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To enable flexible operation according to the surgeon's hand orientation by leveraging the precision tip-processing technology developed for its existing micro forceps.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.